N/A N=44 Satiety and Alcohol Challenge
Alcohol Drinking
Primary: Change in Alcohol Specific Satiety Score — -0.51; 4.85 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=23 Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Prostatic Neoplasms
Primary: Change Rate of Prostate-specific Antigen (PSA) < Nadir + 2 ng/mL From First Day of Treatment to 15 Months (Cohort 2) — 100; 100 percentage of participants
Phase 1 N=63 A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
Non-alcoholic Fatty Liver Disease · Obesity
Primary: Number of Subjects With Drug-related Adverse Events (AEs) — 9; 8; 14; 5 Participants
Phase 4 N=494 The Back Pain Consortium Research Program Study
Chronic Low-back Pain
Primary: Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 4a Between Week 6 (T2) to Week 15 (T3) — -0.9; -1.8; -1.6; -2.0 score on a…
N/A N=202 Impact of a Corrie Cardiac Rehabilitation Program
Coronary Artery Disease · Myocardial Infarction · Myocardial Ischemia
Primary: 6-minute Walking Distance (Meters) — 506.1; 489.8 meters — p=0.04
Phase 1 N=16 A Study of [¹⁴C]-LY3484356 in Healthy Female Participants
Healthy
Primary: Part 1: Pharmacokinetics (PK): Fecal Excretion of LY3484356 Radioactivity Over Time Expressed as a Percentage of the Total Radioactive Dose Administered — 97.3…
N/A N=184 Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
Post-Operative Nausea and Vomiting · Breast Cancer
Primary: Efficacy of Intervention to Prevent Post-Operative Nausea and Vomiting (PONV) — 19; 12; 67; 71 Participants — p=0.2787
N/A N=54 Proton Radiation for Chordomas and Chondrosarcomas
Chordomas · Chondrosarcomas
Primary: Feasibility of Proton RT for Chordomas and Chondrosarcomas — 3.7; 1.9 percentage of patients did not meet this
Phase 2 N=286 A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Crohn Disease · Colitis, Ulcerative
Primary: Number of Participants With Moderate to Severe UC Who Showed Clinical Remission as Defined by the MMS — 9; 17; 22 Participants
Phase 4 N=104 Comparison of the Efficiency of Femur Nerve Block and Intravenous Analgesia Treatment in Hip Fracture Patients
Hip Fractures · Analgesia · Femoral Nerve
Primary: Pain Score Change — 4; 2 units on a scale
Phase 2 N=264 A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age
Healthy
Primary: Number of Participants With Solicited Local Adverse Reactions (ARs) and Systemic ARs — 46; 68; 5; 34 Participants
N/A N=95 Identifying Therapeutic Targets of Accelerated Sarcopenia
Sarcopenia · Diabetes Mellitus · Aging
Primary: Leg Lean Mass — 0.35; -0.55; -0.80; -0.44 kg — p=<0.01
Phase 2 N=247 A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
Uremic Pruritus
Primary: Change From Baseline in the Mean NRS Score at Week 8 of the Treatment Period — -2.97; -3.65; -3.64; -2.86 points — p=0.770
N/A N=138 BullyDown, a Text Messaging-based Bullying Prevention Program for Middle School-aged Youth
Bullying
Primary: Feasibility: Recruitment Rate — 202 Participants
Phase 4 N=60 Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
Diabetes Mellitus, Type 2 · Obesity · Gastroparesis
Primary: Presence of RGV (Residual Gastric Volume) in Stomach — 7; 1 Participants